P24821 (TENA_HUMAN) Homo sapiens (Human)

Tenascin UniProtKBInterProSTRINGInteractive Modelling

2201 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6)

Available Structures

18 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the C-terminal Fg domain of TNC with the single FN domain of PTPRZ Heteromer
P23471;
1975-2191
CA;
Assess
Novel non-antibody protein scaffold targeting CD40L Heteromer
P29965;
809-893
NAG;
Assess
High resolution design of a protein loophomo-2-mer803-891
Assess
Crystal structure of the C-terminal Fg domain of human TNC with the mutations Y2140H and S2164Hmonomer1976-2194
CA;SO4;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
K1P;
Assess
Fibrinogen-like globe domain of Human Tenascin-Cmonomer1979-2194
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RXJ;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
NTV;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RWS;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RWV;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
JGG;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RXS;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
EJQ;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RX7;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
AXS;
Assess
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENA…monomer1979-2194
RXG;
Assess
High resolution design of a protein loopmonomer802-893
Assess
STRUCTURE OF A FIBRONECTIN TYPE III DOMAIN FROM TENASCIN PHASED BY MAD ANALYSIS OF THE SELENOMETHIO…monomer802-891
Assess

15 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1fnf.1.Amonomer0.621620-1968
24.07
Assess
1fnf.1.Amonomer0.621545-1885
28.82
Assess
3t1w.1.Amonomer0.611619-1974
23.88
Assess
6mfa.1.Amonomer0.611619-1970
22.79
Assess
6mfa.1.Amonomer0.61711-1067
24.93
Assess
3t1w.1.Amonomer0.61802-1156
23.01
Assess
1fnf.1.Amonomer0.61623-978
26.06
Assess
3t1w.1.Amonomer0.60622-981
25.49
Assess
3t1w.1.Amonomer0.59712-1071
22.63
Assess
7nwl.1.Cmonomer0.58713-1065
25.07
Assess
6mfa.1.Amonomer0.56623-979
26.57
Assess
1fnf.1.Amonomer0.54893-1253
28.25
Assess
6mfa.1.Amonomer0.541439-1799
22.51
Assess
6mfa.1.Amonomer0.541528-1880
24.20
Assess
3t1w.1.Amonomer0.50985-1340
21.43
Assess

42 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28q6t.1.Imonomer0.51672-1421
16.73
Assess
Isoform 36mfa.1.Amonomer0.63711-1068
24.57
Assess
Isoform 33t1w.1.Amonomer0.63622-983
25.91
Assess
Isoform 31fnf.1.Amonomer0.63803-1153
24.14
Assess
Isoform 33t1w.1.Amonomer0.63802-1158
22.88
Assess
Isoform 31fnf.1.Amonomer0.63623-983
29.49
Assess
Isoform 31fnf.1.Amonomer0.631258-1605
24.43
Assess
Isoform 31fnf.1.Amonomer0.62713-1066
25.00
Assess
Isoform 33t1w.1.Amonomer0.62712-1072
22.56
Assess
Isoform 31fnf.1.Amonomer0.621181-1521
28.82
Assess
Isoform 36mfa.1.Amonomer0.62802-1157
20.74
Assess
Isoform 36mfa.1.Amonomer0.611255-1607
22.79
Assess
Isoform 33t1w.1.Amonomer0.601257-1611
23.94
Assess
Isoform 36mfa.1.Amonomer0.59622-979
26.78
Assess
Isoform 33t1w.1.Amonomer0.581181-1521
25.23
Assess
Isoform 36mfa.1.Amonomer0.561075-1435
22.51
Assess
Isoform 36tpw.1.Amonomer0.54623-979
22.54
Assess
Isoform 36tpw.1.Amonomer0.53712-1072
21.41
Assess
Isoform 36tpw.1.Amonomer0.531256-1610
18.64
Assess
Isoform 36mfa.1.Amonomer0.531164-1516
24.20
Assess
Isoform 31fnf.1.Amonomer0.50893-1239
28.10
Assess
Isoform 41fnf.1.Amonomer0.63623-983
29.49
Assess
Isoform 58q6t.1.Imonomer0.53622-1247
16.67
Assess
Isoform 58q6t.1.Imonomer0.53628-1331
18.42
Assess
Isoform 58q6t.1.Pmonomer0.52622-1247
16.67
Assess
Isoform 58q6t.1.Pmonomer0.51628-1331
18.42
Assess
Isoform 58q6t.1.Pmonomer0.51713-1423
16.74
Assess
Isoform 58q6t.1.Imonomer0.51713-1423
16.74
Assess
Isoform 58q6t.1.Pmonomer0.51622-1423
17.86
Assess
Isoform 68q6t.1.Imonomer0.55622-1155
19.09
Assess
Isoform 68q6t.1.Pmonomer0.54713-1331
17.86
Assess
Isoform 68q6t.1.Pmonomer0.54622-1155
19.09
Assess
Isoform 68q6t.1.Pmonomer0.54628-1239
19.44
Assess
Isoform 68q6t.1.Imonomer0.54713-1331
17.86
Assess
Isoform 68q6t.1.Imonomer0.54622-1331
19.83
Assess
Isoform 68q6t.1.Pmonomer0.53622-1331
19.83
Assess
Isoform 68q6t.1.Imonomer0.53628-1239
19.44
Assess
Isoform 68g4l.37.Amonomer0.53622-1330
18.38
Assess
Isoform 68g4l.38.Amonomer0.53622-1330
18.38
Assess
Isoform 68g4l.38.Amonomer0.53626-1155
20.38
Assess
Isoform 68g4l.38.Amonomer0.51622-1239
19.38
Assess
Isoform 68g4l.37.Amonomer0.51626-1155
20.38
Assess